Leptin in Joint and Bone Diseases: New Insights
Authors: Scotece, M.; Conde, J.; Lopez, V.; Lago, F.; Pino, J.; J. Gomez-Reino, J.; Gualillo, O.
Source: Current Medicinal Chemistry, Volume 20, Number 27, September 2013 , pp. 3416-3425(10)
Publisher: Bentham Science Publishers
Abstract:Leptin is an adipokine with pleiotropic actions that regulates food intake, energy metabolism, inflammation and immunity, and also participates in the complex mechanism that regulates skeleton biology, both at bone and cartilage level. Leptin is increased in obesity and contributes to the “low-grade inflammatory state” of obese subjects causing a cluster of metabolic aberrations that affects joints and bone. In this review, we report the most recent research advances about the role of leptin in bone and cartilage function and its implication in inflammatory and degenerative joint diseases, such as osteoarthritis, rheumatoid arthritis and osteoporosis.
Document Type: Research Article
Publication date: September 1, 2013
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.